Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 5;4(3):229-232.
doi: 10.1017/cts.2020.19.

The role of data and safety monitoring boards in implementation trials: When are they justified?

Affiliations

The role of data and safety monitoring boards in implementation trials: When are they justified?

Kevin Fiscella et al. J Clin Transl Sci. .

Abstract

The National Institutes of Health requires data and safety monitoring boards (DSMBs) for all phase III clinical trials. The National Heart, Lung and Blood Institute requires DSMBs for all clinical trials involving more than one site and those involving cooperative agreements and contracts. These policies have resulted in the establishment of DSMBs for many implementation trials, with little consideration regarding the appropriateness of DSMBs and/or key adaptations needed by DSMBs to monitor data quality and participant safety. In this perspective, we review the unique features of implementation trials and reflect on key questions regarding the justification for DSMBs and their potential role and monitoring targets within implementation trials.

Keywords: Clinical trials data monitoring committee; National Institutes of Health; clinical trials as topic; data and safety monitoring; delivery science; implementation science; translational medical research.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Williams SK, Johnson BA, Tobin JN, et al. Protocol paper: stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV. Progress in Cardiovascular Diseases 2020. doi: 10.1016/j.pcad.2020.02.003 - DOI - PMC - PubMed
    1. Fiscella K, Ogedegbe G, He H, et al. Blood pressure visit intensification study in treatment: trial design. American Heart Journal 2015; 170(6): 1202–1210. - PMC - PubMed
    1. Gordon VM, Sugarman J, Kass N. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials. IRB 1998; 20(1): 1–5. - PubMed
    1. U.S. Department of Health and Human Services. Electronic Code of Federal Regulations: eCFR, Part 46-Protections of Human Subjects, 46.102 (e) [Internet], 2018 [cited Jan 31, 2020]. (https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=83cd09e1c0f5c6937cd9d7...)
    1. Slutsky AS, Lavery JV. Data safety and monitoring boards. The New England Journal of Medicine 2004; 350(11): 1143–1147. - PubMed

LinkOut - more resources